Cargando…

Relevance of ERCC1, RRM1 and BRCA1 in surgically treated non-small cell lung cancer patients

Detalles Bibliográficos
Autores principales:	Pesta, Martin, Topolcan, Ondrej, Kulda, Vlastimil, Fiala, Ondrej, Krakorova, Gabriela, Cerny, Radim, Pesek, Milos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125803/ http://dx.doi.org/10.1186/1878-5085-5-S1-A27

Ejemplares similares

May CTC technologies promote better cancer management?
por: Pesta, Martin, et al.
Publicado: (2015)

The Expression of ERCC1, RRM1, and BRCA1 in Breast Cancer According to the Immunohistochemical Phenotypes
por: Kim, Dokyung, et al.
Publicado: (2011)

Thyroid transcription factor 1 and p63 expression is associated with survival outcome in patients with non-small cell lung cancer treated with erlotinib
por: Svaton, Martin, et al.
Publicado: (2020)

Plasma microRNA Levels Combined with CEA and CA19-9 in the Follow-Up of Colorectal Cancer Patients
por: Pesta, Martin, et al.
Publicado: (2019)

Prognostic Significance of Lymph Node Examination by the OSNA Method in Lung Cancer Patients—Comparison with the Standard Histopathological Procedure
por: Vodicka, Josef, et al.
Publicado: (2020)

Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?
por: Valsecchi, Matias E, et al.
Publicado: (2012)

Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer
por: Cao, Yongkuan, et al.
Publicado: (2017)

Education in personalized medicine in Czech Republic
por: Karlikova, Marie, et al.
Publicado: (2014)

ERCC1、RRM1和TS在非小细胞肺癌中的临床意义
Publicado: (2014)

Knowledge and innovation communities, new potential for biomedical research in Europe
por: Kinkorova, Judita, et al.
Publicado: (2014)

Current status of biomarker research in neurology
por: Polivka, Jiri, et al.
Publicado: (2016)

Expression levels of ERCC1 and RRM1 mRNA and clinical outcome of advanced non-small cell lung cancer
por: Jian-wei, Bi, et al.
Publicado: (2013)

Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapy
por: Leng, Xue-Feng, et al.
Publicado: (2012)

ERCC1 and RRM1 as a predictive parameter for non-small cell lung, ovarian or pancreas cancer treated with cisplatin and/or gemcitabine
por: Ulker, Mehmet, et al.
Publicado: (2015)

The Predictive Value of ERCC1, RRM1, and Thymidylate Synthase in Advanced Malignant Pleural Mesothelioma Patients Treated with Platinum-Based Chemotherapy
por: Wahba, Nagwa Ismail, et al.
Publicado: (2023)

10th Anniversary of the European Association for Predictive, Preventive and Personalised (3P) Medicine - EPMA World Congress Supplement 2020
por: Golubnitschaja, Olga, et al.
Publicado: (2020)

The application of personalized medicine in neurooncology
por: Polivka Jr, Jiri, et al.
Publicado: (2014)

Prognostic value of tumor markers in malignant melanoma
por: Treskova, Inka, et al.
Publicado: (2014)

Serum levels of markers in early detection of prostate cancer (pilote study)
por: Fuchsova, Radka, et al.
Publicado: (2014)

The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival
por: Tantraworasin, Apichat, et al.
Publicado: (2013)

The expression of ERCC1 and BRCA1 predicts prognosis of platinum-based chemotherapy in urothelial cancer
por: Song, Wenhui, et al.
Publicado: (2016)

Stroke care in West Bohemia – personalised medicine approach
por: Polivka, Jiri, et al.
Publicado: (2014)

RRM1 *151A>T, RRM1 ‐756T>C, and RRM1 ‐585T>Gis associated with increased susceptibility of lung cancer in Chinese patients
por: Xu, Xiao‐Ling, et al.
Publicado: (2016)

Expression of ERCC1, TYMS, TUBB3, RRM1 and TOP2A in patients with esophageal squamous cell carcinoma: A hierarchical clustering analysis
por: YU, YONGKANG, et al.
Publicado: (2014)

RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin
por: Muñoz-Montaño, Wendy, et al.
Publicado: (2021)

Association between TOP2A, RRM1, HER2, ERCC1 expression and response to chemotherapy in patients with non-muscle invasive bladder cancer
por: Liu, Zhifei, et al.
Publicado: (2022)

Circulating Tumor DNA correlates with Lactate Dehydrogenase, CYFRA 21-1, and CRP levels in patients with advanced NSCLC
por: Buresova, Marcela, et al.
Publicado: (2023)

BRCA1 testing in Lithuania
por: Janavicius, Ramunas
Publicado: (2012)

The activities of the young professionals EPMA in the Czech Republic
por: Polivka Jr , Jiri, et al.
Publicado: (2014)

Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients
por: Boukovinas, Ioannis, et al.
Publicado: (2008)

Expression of ERCC1, RRM1, TUBB3 in correlation with apoptosis repressor ARC, DNA mismatch repair proteins and p53 in liver metastasis of colorectal cancer
por: Tóth, Csaba, et al.
Publicado: (2017)

Optimalization of recovery, regeneration and rehabilitation
por: Novak, Jaroslav, et al.
Publicado: (2014)

Haplotype analysis in German families with recurrent BRCA1 and BRCA2 mutations
por: Wappenschmidt, B, et al.
Publicado: (2001)

Personalized Prescription of Chemotherapy Based on Assessment of mRNA Expression of BRCA1, RRM1, ERCC1, TOP1, TOP2α, TUBβ3, TYMS, and GSTP1 Genes in Tumors Compared to Standard Chemotherapy in the Treatment of Non-Small-Cell Lung Cancer
por: Tsyganov, Matvey M., et al.
Publicado: (2022)

ERCC1, RRM1 and TUBB3 mRNA expression on the tumor response and overall survival of non-small cell lung cancer treated with platinum-based chemotherapy
por: Qiao, Hongwei, et al.
Publicado: (2014)

Aggressive pulmonary adenocarcinoma with new FGFR translocation and cMET mutation not responsive to crizotinib and nintedanib treatment: a case report
por: Svaton, Martin, et al.
Publicado: (2020)

Germline mutations of BRCA1-associated RING domain (BARD1) gene in breast and/or ovarian families negative for BRCA1 and 2 alterations
por: Ghimenti, C, et al.
Publicado: (2000)

Selenium and the risk of cancer in BRCA1 carriers
por: Lubinski, J, et al.
Publicado: (2011)

ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel
por: Wang, Lifeng, et al.
Publicado: (2008)

BRCA1 and ERCC1 mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer
por: Yuanming, Lu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jn1kaov77i7fsc9vmc8rge3pcq